Lawrence G. McMillan: Trouble in paradise: Sell signs are popping up across the stock market
Keep a core bullish position but decrease exposure to stocks.
The Price of Risk: With Equity Risk Premiums, Caveat Emptor!
If you have been reading my posts, you know that I have an obsession with equity risk premiums, which I believe lie at...
: UBS nears major investment-bank restructuring: report
Continued integration of Credit Suisse after emergency takeover spurs plans for reshuffling UBS's deal teams, Reuters reports.
: Millennials are losing the home-buying edge to baby boomers
The U.S. housing market is slipping away from the millennial generation, according to the National Association of Realtors.
Retirement: Are inflation and debt pushing you to raid your retirement savings early? You’re not alone.
More Americans are feeling the financial pinch thanks in part to inflation and debt, and they’re looking to their retirement savings for help now.
Earnings Results: Warren Buffett’s Berkshire Hathaway swings to Q2 profit, operating earnings up 6%
Berkshire Hathaway swung to a profit in the second quarter, owed to its investment portfolio and insurance holdings, according to a release out Saturday.
Goldman Sachs’ future hinges on a low-profile, high-growth business
Goldman Sachs CEO David Solomon has hitched his fortunes to asset and wealth management after dropping his ill-fated retail banking effort.
No more freebies: Companies crack down on customer perks and rewards
Companies from Dunkin' to Delta, Netflix to Sephora are pulling back on freebies and perks as they chase higher margins.
: FDA approves first-ever pill for postpartum depression in new mothers
Biogen and Sage Therapeutics are behind the first FDA-approved pill for treating postpartum depression.